CJC-1295 + Ipamorelin is the most-studied stack in G13’s GH secretagogue category.
Classification
The stack pairs a GHRH analogue (CJC-1295) with a selective ghrelin-receptor agonist (Ipamorelin). The two act on complementary mechanisms, which is why they are so often researched in combination.
In research
Studied in pulsatile GH-release research, where the combined GHRH + GHRP activity is the variable of interest. Mechanism for research reference only.
Specifications & verification
5mg/5mg lyophilized vial, ≥99% purity standard; store at -20°C. Independent, lot-matched HPLC COA (current lot CS-ci101021).
Research reference material for laboratory research use only. Not for human consumption.